Determination of the ID50 values of antibacterial agents in agar.

PubWeight™: 3.08‹?› | Rank: Top 1%

🔗 View Article (PMID 368001)

Published in J Antibiot (Tokyo) on December 01, 1978

Authors

T Kato, S Kurashige, Y A Chabbert, S Mitsuhashi

Articles citing this

In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28

Cefroxadine (CGP-9000), an orally active cephalosporin. Antimicrob Agents Chemother (1980) 0.75

Articles by these authors

The transcriptional landscape of the mammalian genome. Science (2005) 37.63

In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28

In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31

Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrob Agents Chemother (1981) 8.59

In vitro hemolytic characteristic of Vibrio parahaemolyticus: its close correlation with human pathogenicity. J Bacteriol (1969) 8.04

Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci. J Gen Microbiol (1968) 7.97

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection (1984) 7.53

In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 7.35

Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11

Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 7.10

The rate of loss of weight in skeletal muscle after nerve section with some observations on the effect of stimulation and other treatment. J Physiol (1915) 6.49

Plasmid-linked tetracycline and erythromycin resistance in group D "streptococcus". Ann Inst Pasteur (Paris) (1972) 6.44

Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother (1986) 6.03

Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother (1986) 6.00

Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol (1999) 5.84

Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light. Mol Gen Genet (1977) 5.61

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs (1996) 5.45

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care (1999) 5.37

Studies on the enteropathogenic, facultatively halophilic bacterium, Vibrio parahaemolyticus. 3. Enteropathogenicity. Jpn J Med Sci Biol (1968) 5.35

The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli. J Biochem (1969) 5.35

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26

Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1987) 4.96

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94

Incompatibility groups and the classification of fi - resistance factors. J Bacteriol (1972) 4.91

Identification of CRE1 as a cytokinin receptor from Arabidopsis. Nature (2001) 4.77

In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin. Antimicrob Agents Chemother (1979) 4.49

In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob Agents Chemother (1989) 4.38

The physiological action of physostigmine and its action on denervated skeletal muscle. J Physiol (1915) 4.37

RecA protein-dependent cleavage of UmuD protein and SOS mutagenesis. Proc Natl Acad Sci U S A (1988) 4.12

R plasmids in Streptococcus agalactiae (group B). Antimicrob Agents Chemother (1976) 4.12

A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett (1967) 4.11

Purification and properties of a new beta-lactamase from Pseudomonas cepacia. Antimicrob Agents Chemother (1980) 4.09

Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants. J Infect Dis (1971) 4.06

Arabidopsis NPL1: a phototropin homolog controlling the chloroplast high-light avoidance response. Science (2001) 3.93

Regulation of drought tolerance by gene manipulation of 9-cis-epoxycarotenoid dioxygenase, a key enzyme in abscisic acid biosynthesis in Arabidopsis. Plant J (2001) 3.92

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88

In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrob Agents Chemother (1987) 3.84

In vitro and in vivo antibacterial activity of AT-2266. Antimicrob Agents Chemother (1983) 3.80

Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli. Antimicrob Agents Chemother (1986) 3.69

Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates. Antimicrob Agents Chemother (1978) 3.65

Biochemical properties of beta-lactamase produced by Flavobacterium odoratum. Antimicrob Agents Chemother (1985) 3.62

Properties of novel beta-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother (1983) 3.59

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob Agents Chemother (1988) 3.52

Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother (1980) 3.48

Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 3.40

Variant of penicillinase mediated by an R factor in Escherichia coli. J Bacteriol (1970) 3.33

Corneal neovascularization. Curr Opin Ophthalmol (2001) 3.22

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18

In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob Agents Chemother (1987) 3.12

Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother (1984) 3.07

Base-change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics (1970) 3.05

Drug resistance of enteric bacteria. XIV. Comparison of beta-lactamases in gram-negative rod bacteria resistant to alpha-aminobenzylpenicillin. Jpn J Microbiol (1968) 3.04

Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant. J Bacteriol (1987) 3.04

In vitro and in vivo antibacterial activity of AB206, a new naphthyridine derivative. Antimicrob Agents Chemother (1980) 2.98

Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol (1997) 2.89

Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. Antimicrob Agents Chemother (1980) 2.76

Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin. Antimicrob Agents Chemother (1981) 2.72

Taxonomy and epidemiology of gram-negative bacterial plasmids studied by DNA-DNA filter hybridization in formamide. J Gen Microbiol (1978) 2.71

Biochemical properties of a penicillin beta-lactamase mediated by R factor from Bordetella bronchiseptica. Antimicrob Agents Chemother (1975) 2.70

Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62

Hyperammonaemia and Helicobacter pylori. Lancet (1995) 2.59

Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli. Eur J Biochem (1979) 2.58

Conjugative R plasmids in Streptococcus agalactiae (group B). Plasmid (1979) 2.57

Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor. Science (1967) 2.55

Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains. Antimicrob Agents Chemother (1980) 2.53

Biochemical properties of a cephalosporin beta-lactamase from Pseudomonas aeruginosa. Jpn J Microbiol (1973) 2.50

ARR1, a transcription factor for genes immediately responsive to cytokinins. Science (2001) 2.50

Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut (2001) 2.49

In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 2.43

Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob Agents Chemother (1982) 2.43

Purification and some properties of a cephalosporinase from Proteus vulgaris. Antimicrob Agents Chemother (1981) 2.42

Genetic evidence that the endodermis is essential for shoot gravitropism in Arabidopsis thaliana. Plant J (1998) 2.41

Spectrodensitometric determination of trichothecene mycotoxins with 4-(p-nitrobenzyl)pyridine on silica gel thin-layer chromatograms. J Chromatogr (1979) 2.38

Genetic and molecular characteristics of X-ray-sensitive mutants of Escherichia coli defective in repair synthesis. J Bacteriol (1970) 2.37

Purification and properties of a cephalosporinase from Enterobacter cloacae. Antimicrob Agents Chemother (1980) 2.37

The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33

Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1987) 2.33

Structural analysis of the umu operon required for inducible mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.30

Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391. J Gen Microbiol (1980) 2.28

Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol (2001) 2.27

Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27

An enzymatic cycling method for nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases. Anal Biochem (1973) 2.22

In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin. Chemotherapy (1990) 2.19

Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants. Antimicrob Agents Chemother (1983) 2.19

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Letter: Two beta-lactamase inhibitors produced by a streptomyces. J Antibiot (Tokyo) (1973) 2.16

Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16

Suppression of the heterotrimeric G protein causes abnormal morphology, including dwarfism, in rice. Proc Natl Acad Sci U S A (1999) 2.15

Drug resistance to staphylococci. 3. Resistance to some macrolide antibiotics and inducible system. Jpn J Microbiol (1966) 2.13

In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother (1992) 2.10

Biochemical properties of beta-lactamase produced by Legionella gormanii. Antimicrob Agents Chemother (1986) 2.10

Subtractive cDNA cloning using oligo(dT)30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res (1991) 2.08

In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob Agents Chemother (1988) 2.08

In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agents Chemother (1990) 2.05

[Transferable resistance to gentamicin. I. Expression of the resistance character]. Ann Inst Pasteur (Paris) (1971) 1.99

The endodermis and shoot gravitropism Trends Plant Sci (1999) 1.98

Role of the putative membrane-bound endo-1,4-beta-glucanase KORRIGAN in cell elongation and cellulose synthesis in Arabidopsis thaliana. Plant Cell Physiol (2001) 1.97